research Defects in Androgen Biosynthesis Causing 46,XY Disorders of Sexual Development
Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.
Search
forLearn
0 / 0 results — no results
Research
5 / 733 results
research Androgen Biosynthesis and Gene Defects
Gene mutations can cause problems in male genital development.
research Targets to Treat Androgen Excess in Polycystic Ovary Syndrome
The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.
research Steroidogenesis of the Testis: New Genes and Pathways
New genes and pathways are important for testosterone production and male sexual development.
research Correlation Between COVID-19 and Telogen Effluvium and Its Social Impacts
COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.
Community Join
5 / 18 resultscommunity Pérdida de cabello en jóvenes (15-20 años) mi experiencia.
A 19-year-old shares his hair loss experience and treatment routine, which includes 1mg finasteride daily, 2mg oral minoxidil daily, ketoconazole shampoo every 2 days, and a healthy lifestyle. He notes that oral minoxidil is showing better results than topical minoxidil.
community DHT LEVEL IS 700pg/ml AFTER 8 MONTHS OF DUTASTERIDE
The user had high DHT levels after 8 months on dutasteride, questioning the drug's authenticity. They got dutasteride from a legitimate source and will update on progress.
community 2018 - 2024 (Fin -> Fin + Min)
The user shared progress on hair loss treatment, starting finasteride in 2018 and adding minoxidil in November 2023, with significant improvement. The user started treatment at age 31.
community Do you see any progress? 9 months in.
The user has been using minoxidil, dutasteride, and mesotherapy for hair loss for 9 months and recently added a derma-roller to their routine. Commenters agree there is visible progress and improvement in hair thickness.
community Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China
The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.